GLP-1 Scorecard · Published boards · Updated July 2026
Every ranking we grade.
37 providers on the roster, all scored on the same six weighted dimensions. Pick the board that matches the decision in front of you. No provider links on this page — it is an index, not a recommendation.
The weights behind every board
- Cost value25%
- Dose & formulation20%
- Clinical oversight20%
- Labs & monitoring15%
- Fulfillment12%
- Contract terms8%
Full detail in how the WeighScore is calculated and the methodology.
Graded by molecule
Same six dimensions, same weights, narrowed to the drug you have chosen.
- 35graded with a semaglutide price
Best semaglutide providers
The report card on semaglutide programmes, graded A–F on cost value, oversight and contract terms.
For you if semaglutide is settled and quality is what is left to decide.
Open the scorecard →
- 33graded with a tirzepatide price
Best tirzepatide providers
Each grade broken into its six weighted components — the factor carrying the score, and the one costing the most points.
For you if you want to see the arithmetic behind a total rather than take it on trust.
Open the scorecard →
Graded against price
The same roster re-sorted so the cheapest leads, whatever it grades.
Deciding something earlier than a provider?
Start with semaglutide vs. tirzepatide for the trial evidence, compounded vs. brand-name GLP-1 for what you are actually buying, what compounded GLP-1 costs per month for the price ranges, or weight regain after stopping before committing to a year of treatment. Two names can also go side by side on the comparison tool.
How we make money. GLP-1 Scorecard is reader-supported — take it as given that any provider we list may compensate us when you sign up through our links, at no extra cost to you. Affiliate partners are listed first on the board, capped at a 3-point edge in order only. A commission never moves the WeighScore itself — that number is the published weighted average of the same six factors we print for every provider, so you can check our arithmetic. See our disclosure.